L Gugliotta

Medicine · Health Sciences

24h-index2.2kcitations114works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(46), Platelet Disorders and Treatments(31), Chronic Myeloid Leukemia Treatments(27), Chronic Lymphocytic Leukemia Research(18), Hemoglobinopathies and Related Disorders(14)

Publications114 total

Surgical stabilisation of a traumatic cervical subluxation in a cat
Journal of Feline Medicine and Surgery Open Reports·2024Open Access
LEUKEMIC TRANSFORMATION AND SECOND CANCERS IN 3649 HIGH RISK ET PATIENTS IN THE EXELS STUDY
Haematologica·2017Open Access
Treatment of high risk ET – data from the EXELS study
Leukemia Research·2016
Rate Of Malignant Transformation In High Risk Et During 5 Years Of Follow-Up Of Cytoreductive Therapy
Haematologica·2016· 1 citedOpen Access
Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment?
International Journal of Cardiology·2015· 10 cited
Treatment Of Essential Thrombocythemia In Europe : Observational Study Of 3649 Patients Of High Risk (Exels)
Haematologica·2015Open Access
Treatment of essential thrombocythaemia in Europe : an observational study of 3649 high-risk patients in EXELS
2015
RISK FACTORS FOR THROMBOHEMORRHAGIC AND TRANSFORMATION EVENTS IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA : RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY
Haematologica·2015· 1 citedOpen Access
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study
Haematologica·2013· 26 citedOpen Access
The exels study : Real-world cytoreductive treatment patterns for essential thrombocythaemia in Europe (analysis of 3643 patients)
2013
Cytoreductive treatment patterns for essential thrombocythaemia in Europe : analysis of 3643 patients in the EXELS study
British Journal of Haematology·2013
Caspofungin for invasive aspergillosis: A single-centre prospective study
Journal of Clinical Oncology·2009· 1 cited
A451 Superiority of VTD over TD Incorporated Into ASCT for Newly Diagnosed MM
Clinical Lymphoma & Myeloma·2009
Leucocytosis is a risk factor for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
2009
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
Haematologica·2008· 352 citedOpen Access
Effectiveness and Safety of Combined Cytoreductive Therapy In 56 Patients With Essential Thrombocythaemia: Report of the Registro Italiano Trombocitemie (rit)
2008
Cardiovascular evaluation in 232 patients with essential thrombocythemia (ET) treated with ana- grelide: report of the Registro Italiano Trombocitemia (RIT)
2008
Abstract
Journal of Thrombosis and Haemostasis·2007Open Access
Erratum: A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group
Leukemia·2007
Abnormal Intracellular Level of Bax in CD3 + Cells from Untreated B-Cell Chronic Lymphocytic Leukemia Patients
Laboratory Hematology·2006Open Access
page 1 of 6Next →

Frequent Co-authors

S Tura(24), Nicola Vianelli(23), Lucia Catani(17), Michele Baccarani(6), Tiziano Barbui(5), Giuseppe Visani(5), S Baravelli(5), Anna Guarini(5), Guido Finazzi(4), Giorgio Zauli(4), Stefano Sacchi(4), Giuseppe Bandini(4), Monica Mattioli‐Belmonte(4), Silvia Macchi(4), Valerio De Stefano(3), Alessia Tieghi(3), Giuseppe Leone(3), Franco Mandelli(3), E Bobbio-Pallavicini(3), Riccardo Centurioni(3)